FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma.
Jiao HuangWai Ying TsangXiao-Na FangYu ZhangJie LuoLan-Qi GongBai-Feng ZhangChing Ngar WongZhi-Hong LiBei-Lei LiuJin-Lin HuangYu-Ma YangShan LiuLiu-Xian BanYiu Hong ChanXin-Yuan GuanPublished in: Cancer research (2024)
Inhibition of FASN increases MHC-I protein levels by suppressing its palmitoylation and lysosomal degradation, which stimulates immune activity against hepatocellular carcinoma and enhances the efficacy of immune checkpoint inhibition.